New patent for Msd Merck drug RECARBRIO
Drug Patent Watch
JUNE 16, 2024
Annual Drug Patent Expirations for RECARBRIO Recarbrio is a drug marketed by Msd Merck Co and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
Let's personalize your content